Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Andersen

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Tidsskriftet Sykepleien|December 5, 1997
[Quality of life--good pressure sore treatment is not enough]M H Andersen
Leukemia|April 3, 2014
The targeting of immunosuppressive mechanisms in hematological malignanciesM H Andersen
Histology and Histopathology|April 19, 2002
Survivin--a universal tumor antigenM H Andersen, Straten P thor
Memorias Do Instituto Oswaldo Cruz|January 1, 1975
[Thermosensitive lethal mutants in Aspergillus nidulans]P C De Oliveira, M H Andersen
Leukemia|December 25, 2004
The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patientsM H Andersen, J C Becker, P Thor Straten
Blood Cancer Journal|July 19, 2014
The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunityS M Ahmad, I M Svane, M H Andersen
Journal of Immunological Methods|February 3, 1998
An improved assembly assay for peptide binding to HLA-B*2705 and H-2K(k) class I MHC moleculesL Tan, M H Andersen, T Elliott, et al.
Current Medicinal Chemistry|July 28, 2012
Cellular based cancer vaccines: type 1 polarization of dendritic cellsM Hansen, Ö Met, I M Svane, et al.
Biochemistry|May 6, 1997
Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domainsM H Andersen, L Berglund, J T Rasmussen, et al.
Advances in Immunology|July 4, 2001
MHC-restricted T cell responses against posttranslationally modified peptide antigensI B Kastrup, M H Andersen, T Elliott, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Tidsskriftet Sykepleien|December 5, 1997
[Quality of life--good pressure sore treatment is not enough]M H Andersen
Leukemia|April 3, 2014
The targeting of immunosuppressive mechanisms in hematological malignanciesM H Andersen
Histology and Histopathology|April 19, 2002
Survivin--a universal tumor antigenM H Andersen, Straten P thor
Memorias Do Instituto Oswaldo Cruz|January 1, 1975
[Thermosensitive lethal mutants in Aspergillus nidulans]P C De Oliveira, M H Andersen
Leukemia|December 25, 2004
The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patientsM H Andersen, J C Becker, P Thor Straten
Blood Cancer Journal|July 19, 2014
The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunityS M Ahmad, I M Svane, M H Andersen
Journal of Immunological Methods|February 3, 1998
An improved assembly assay for peptide binding to HLA-B*2705 and H-2K(k) class I MHC moleculesL Tan, M H Andersen, T Elliott, et al.
Current Medicinal Chemistry|July 28, 2012
Cellular based cancer vaccines: type 1 polarization of dendritic cellsM Hansen, Ö Met, I M Svane, et al.
Biochemistry|May 6, 1997
Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domainsM H Andersen, L Berglund, J T Rasmussen, et al.
Advances in Immunology|July 4, 2001
MHC-restricted T cell responses against posttranslationally modified peptide antigensI B Kastrup, M H Andersen, T Elliott, et al.
Pageof 6